THE DEAL, AT A GLANCE
From the announcementImmuneel Therapeutics
01What it doesKiran Mazumdar-Shaw's Immuneel Therapeutics is a Bengaluru-based Digital Health company focused on scale CAR-T therapies - The HinduBusinessLine.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by a mix of new, </strong>, Singularity AMC, Rainmatter by zerodhaFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedImmuneel Therapeutics raised $12M Series B, announced 2026-06-08From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersImmuneel Therapeutics' $12M Series B is a small healthcare and life sciences financing signal relative to recent sector activity, positioning the round as targeted…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Immuneel Therapeutics · Financing Record
Explore source-linked visual explanations for Immuneel Therapeutics. Unsupported claims are withheld while source review continues.
Record 5702 · Recorded date: 2026-06-08
Explore company records →